Melanogenesis Inhibitory Effects of Methanolic Extracts of Umbilicaria esculenta and Usnea longissima

  • Published : 2007.12.31

Abstract

The primary objective of this study was to assess the in vitro melanogenesis inhibitory effects of methanolic extracts of the edible and medicinal lichens, Umbilicaria (Gyrophora) esculenta and Usnea longissima. The quantities of the total phenolic compounds of methanolic extract of the two lichen extracts were determined to be 1.46% and 2.62%, respectively. In order to evaluate the antioxidative effects of the extracts, we also measured electron donating abilities (EDA) and lipid peroxidation rates. The EDA values measured by the reduction of 1.1'-diphenyl-2-picrylhydrazyl (DPPH) were 72.8% and 80.7% for the extracts, with $SC_{50}$ (median scavenging concentration) values of $1.29{\pm}0.05\;mg/ml$ and $1.03{\pm}0.06\;mg/ml$, respectively. The rates of inhibition of lipid peroxidation using linoleic acid were 92.1% and 97.3% for the extracts, with $IC_{50}$ (median inhibitory concentration) values of $0.57{\pm}0.05\;mg/ml$ and $0.53{\pm}0.06\;mg/ml$, respectively. The inhibitory rates of the extracts against tyrosinase were 67.4% and 84.8%, respectively. The extracts were shown to reduce melanin formation in human melanoma cells. Melanin contents in the samples treated with 0.01% and 0.1% U. esculenta were 47.1% and 31.2%, respectively, and those treated with 0.01% and 0.1% Usnea longissima were 51.1% and 34.9%, respectively, whereas a value of 54.0% was registered when ascorbic acid was utilized as a positive control. In addition to direct tyrosinase inhibition, it was determined that the lichen extracts affected the activity of tyrosinase via the inhibition of tyrosinase glycosylation. As a result, the methanolic extracts of U. esculenta and Usnea longissima evidenced melanogenesis inhibitory effects, which occurred via multiple routes.

Keywords

References

  1. AOAC official method of analysis. 1985. 16th ed. Association of official analytical chemists. Washington D.C., USA
  2. Blois, M.S. 1958. Antioxidant determination by the use of a stable free radical. Nature 26, 1194-1204
  3. Crittenden, P.D. and N. Porter. 1991. Lichen forming fungi: potential sources of novel metabolites. Trends Biotechnol. 9, 409-414 https://doi.org/10.1016/0167-7799(91)90141-4
  4. Herbert, R.A. 1992. A perspective on the biotechnological potential of extremophiles. Trends Biotechnol. 10, 395-402 https://doi.org/10.1016/0167-7799(92)90282-Z
  5. Kahng, H.Y., B.J. Yoon, S.H. Kim, D.J. Shin, J.S. Hur, H.W. Kim, E.S. Kang, K.H. Oh, and Y.J. Koh. 2004. Introduction of saxicolous lichens distributed in coastal rocks of U-do islet in Jeju, Korea. J. Microbiol. 42, 292-298
  6. Kim, C.H. 1982. Studies on the substances contained in Gyrophora esculenta lowering plasma and liver cholesterol levels Part 4. J. Iwate Medical Association 34, 669-672
  7. Kim, M.S. and K.A. Lee. 2006. Antithrombotic activity of methanolic extract of Umbilicaria esculenta. J. Ethnopharmacol. 105, 342-345 https://doi.org/10.1016/j.jep.2005.11.011
  8. Lauterwein, M., M. Oethinger, K. Belsner, T. Peters, and R. Marre. 1995. In vitro activities of the lichen secondary metabolites vulpinic acid, (+)-usnic acid, and (-)-usnic acid against aerobic and anaerobic microorganisms. Antimicrob. Agents Chemother. 39, 2541-2543 https://doi.org/10.1128/AAC.39.11.2541
  9. Lee, D.W., K.H. Kim, S.C. Chun, and H.M. Park. 2002. Characterization of cell wall proteins from the soo1-1/ret1-1 mutant of Saccharomyces cerevisiae. J. Microbiol. 40, 219-223
  10. Lee, K.A. and M.S. Kim. 2000. Effect of extract from Umbilicaria esculenta on postprandial hyperglycemia. Korean J. Pharmacog. 31, 101-104
  11. Lo, H.S. 1994. Coloured icones of Chinese medicine, Vol. 2, p. 482-483. Guangdong Science and Technology Press, Guangdong, China
  12. Mallavadhani, U.V., A.V.S. Sudhakar, A. Mahapatra, K. Narasimhan, M. Thirunavokkarasu, and J.A. Elix. 2004. Phenolic and steroidal constituents of the lichen Usnea longissima. Biochem. Syst. Ecol. 32, 95-97 https://doi.org/10.1016/S0305-1978(03)00187-X
  13. Muller, K. 2001. Pharmaceutically relevant metabolites from lichens. Appl. Microbiol. Biotechnol. 56, 9-16 https://doi.org/10.1007/s002530100684
  14. Na, B.K. and C.Y. Song. 2000. Intracellular posttranslational modification of aspartyl proteinase of Candida albicans and the role of the glycan region of the enzyme. J. Microbiol. 38, 218-223
  15. Okuyama, E., K. Umeyama, M. Yamazaki, Y. Kinoshita, and Y. Yamamoto. 1994. Usnic acid and diffractaic acid as analgesic and antipyretic components of Usnea diffracta Vain. Planta Medica 61, 113-1150 https://doi.org/10.1055/s-2006-958027
  16. Osawa, T. 1981. A novel type of antioxidant isolated from leaf was of Eucalyptus leaves. Agric. Biol. Chem. 45, 735-739 https://doi.org/10.1271/bbb1961.45.735
  17. Pawelek, J.M. and A.M. Korner. 1982. The biosynthesis of mammalian melanin. Am. Sci. 70, 136-145
  18. Prota, G. and R.H. Thomson. 1976. Melanin pigmentation in mammals. Endeavor 35, 32-38 https://doi.org/10.1016/0160-9327(76)90060-0
  19. Richardson, D.H.S. 1988. Medicinal and other economic aspects of lichens, p. 93-108. In M. Galun (ed.) Handbook of lichenology, Vol 3. CRC Press, USA
  20. Sone, Y., M. Isoda-Johmura, and A. Misaki. 1996. Isolation and chemical characterization of polysaccharides from Iwatake, Gyrophora esculenta Miyoshi. Biosci. Biotech. Biochem. 60, 213-215 https://doi.org/10.1271/bbb.60.213
  21. Toyofuku, K., I. Wada, R.A. Spritz, and V.J. Hearing. 2001. The molecular basis of oculocutaneous albinism type 1 (OCA1): sorting failure and degradation of mutant tyrosinases results in a lack of pigmentation. Biochem. J. 355, 259-269 https://doi.org/10.1042/0264-6021:3550259
  22. Wong, T.C., B.S. Luh, and J.R. Whitaker. 1971. Isolation and characterization of polyphenol oxidase of clingstone peach. Plant Physiol. 48, 19-23 https://doi.org/10.1104/pp.48.1.19
  23. Yoshimura, I. 1994. Lichen flora of Japan in color, p. 25-40, 58-86, 117-123. Hoikusha Publishing Co. Ltd., Osaka, Japan